title: Acute demyelinating disease after interferon beta-1a treatment for multiple sclerosis.
authors.affiliation: Service de Neurologie, Hôpital Henri Mondor, AP-HP et Université Paris XII, Creteil, France. vonraison@univ-paris12.fr
authors.forename: F
authors.initials: F
authors.lastname: Von Raison
authors.forename: H
authors.initials: H
authors.lastname: Abboud
authors.forename: C
authors.initials: C
authors.lastname: Saint Val
authors.forename: P
authors.initials: P
authors.lastname: Brugières
authors.forename: P
authors.initials: P
authors.lastname: Césaro
mesh_terms: D000328:Adult; D003711:Demyelinating Diseases / Q000209:etiology*; D006801:Humans; D000068556:Interferon beta-1a; D016899:Interferon-beta / Q000009:adverse effects* / Q000627:therapeutic use*; D008279:Magnetic Resonance Imaging; D008297:Male; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy*
chemical_list: D016899:Interferon-beta; D000068556:Interferon beta-1a